drugset / Trial / NCT06959082
Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This will be a multi-center, randomized, open-label, parallel-group study in adult patients with head and neck cancer.
Timeline
- Start
- 2026-06
- Primary completion
- 2027-06
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VS-101 | Unknown | 2 mg | — |
| Subject | VS-101 | Unknown | 5 mg | — |
| Background | Cisplatin | Other / unclassified | — | — |